This compound is primarily utilized in organic synthesis as a versatile building block for the construction of complex molecules. It is particularly valued in the field of medicinal chemistry, where it serves as an intermediate in the development of pharmaceuticals, especially those targeting infectious diseases and cancer. The tributylstannyl group facilitates cross-coupling reactions, such as Stille coupling, enabling the formation of carbon-carbon bonds in the synthesis of bioactive compounds. Additionally, its isoxazole moiety is of interest due to its presence in various biologically active molecules, making it a key component in the design of new drugs with potential therapeutic applications.